Product Information
HYDROMORPHONE HCL ER 16 MG TAB is a generic product labeled by Camber Pharmaceuticals Inc., priced at $12.3802 per EA under NDC 31722012101. Its NADAC has been published 116 times since Apr 17, 2024.
FDA first approved this application on Sep 23, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
16 mg/1
Manufacturer
Camber Pharmaceuticals Inc.NDC
31722012101
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
HYDROMORPHONE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA212133FDA Approved
9/23/2020
TE Code
AB
On Market Since
9/24/2020
Pharmacological Classes
Price Statistics
The NADAC for HYDROMORPHONE HCL ER 16 MG TAB has been published 116 times since Apr 17, 2024, and over the history we have for it it has risen 40.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $12.3802 per EA |
|---|---|
| All-time high | $12.3802 (Sep 30, 2026) |
| All-time low | $7.9003 (May 22, 2024) |
| 52-week high | $12.3802 |
| 52-week low | $9.5750 |
| Median price | $9.5750 |
| Average price | $9.6511 |
| Largest weekly change | +13.0% (May 20, 2026) |
| Weeks tracked | 116 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Camber Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
hydromorphone hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Opioid Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of HYDROMORPHONE HCL ER 16 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for HYDROMORPHONE HCL ER 16 MG TAB, manufactured by Camber Pharmaceuticals Inc., is $12.3802 per EA (NDC 31722012101), effective Sep 30, 2026.
How has the price of HYDROMORPHONE HCL ER 16 MG TAB changed over time?
Over the history we have for it, the NADAC for HYDROMORPHONE HCL ER 16 MG TAB has risen 40.4%. It has been tracked across 116 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for HYDROMORPHONE HCL ER 16 MG TAB?
Since Apr 17, 2024, the NADAC for HYDROMORPHONE HCL ER 16 MG TAB has ranged from a low of $7.9003 (May 22, 2024) to a high of $12.3802 (Sep 30, 2026), with a median of $9.5750 per EA.
Are there cheaper alternatives to HYDROMORPHONE HCL ER 16 MG TAB?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as HYDROMORPHONE HCL ER 16 MG TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures HYDROMORPHONE HCL ER 16 MG TAB?
HYDROMORPHONE HCL ER 16 MG TAB (NDC 31722012101) is labeled by Camber Pharmaceuticals Inc., and CMS classifies it as a generic product.